Puma Biotechnology Aktie
					
						
							4,70
						
						EUR
					
					
						
							+0,22
						
						EUR
					
					
						
							+5,01
						
						%
					
				
				
				
					
						
							5,47
						
						USD
					
					
						
							+0,30
						
						USD
					
					
						
							+5,71
						
						%
					
				
				
		
		
		
		
		
	
                            
        Werbung
    
                        
                            
                                
                            
                        
                    
                Puma Biotechnology Aktie Analyse
| 10.05.19 | Puma Biotechnology Neutral | Cantor Fitzgerald | |
| 01.10.18 | Puma Biotechnology Overweight | Cantor Fitzgerald | |
| 11.05.18 | Puma Biotechnology Buy | Stifel, Nicolaus & Co., Inc. | |
| 10.11.17 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
| 02.10.17 | Puma Biotechnology Buy | Stifel, Nicolaus & Co., Inc. | |
| 06.06.17 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
| 25.05.17 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
| 02.03.17 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
| 
                            
        Werbung
    
                         | |||
| 21.09.16 | Puma Biotechnology Buy | Stifel, Nicolaus & Co., Inc. | |
| 29.03.16 | Puma Biotechnology Sector Perform | RBC Capital Markets | |
| 23.01.15 | Puma Biotechnology Outperform | RBC Capital Markets | |
                            
        Werbung
    
                        
                            
                                
                            
                        
                    
                
                            
        Werbung
    
                        
                            
                                
                            
                        
                    
                 
                                